Clinical Trial Update: Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether aminophylline attenuates the side effect profile of regadenoson in patients with severe chronic kidney disease undergoing nucle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Nuclear Stress Testing of the Heart

Drugs mentioned

• Aminophylline (aminophylline)
• Regadenoson (Regadenoson)

Snippet

Sponsor: Rush University Medical Center | Conditions: Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson | Phase 4 | Status: COMPLETED | Results posted: 2013-02-13